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YqjH is a cytoplasmic FAD-containing protein from Escherichia coli; based on
homology to ViuB of Vibrio cholerae, it potentially acts as a ferri-siderophore
reductase. This work describes its overexpression, purification, crystallization
and structure solution at 3.0 A˚ resolution. YqjH shares high sequence similarity
with a number of known siderophore-interacting proteins and its structure was
solved by molecular replacement using the siderophore-interacting protein from
Shewanella putrefaciens as the search model. The YqjH structure resembles
those of other members of the NAD(P)H:flavin oxidoreductase superfamily.
1. Introduction
Iron is required by virtually all living organisms as a micronutrient.
The ability of iron to easily switch between two relatively stable redox
states (ferric/Fe3+ and ferrous/Fe2+ forms) makes it ideally suited as a
mediator of redox chemistry within biology. However, this redox
activity can create problems for organisms exposed to oxygen since
iron is capable of catalysing the generation of reactive oxygen species
that can cause toxicity and ultimately cell death (Dubrac & Touati,
2000; Touati, 2000). Furthermore, in the presence of oxygen at neutral
(or higher) pH, the relatively soluble ferrous form (solubility of 0.1M
at pH 7.0) is rapidly converted to the poorly soluble ferric form
(solubility of 1018 M at pH 7.0), leading to low iron bioavailability
(Andrews et al., 2003). Thus, lack of iron is a common form of
malnutrition in nature and most organisms utilize specific iron-
acquisition systems to enable them to scavenge it from their envir-
onment to counter iron restriction.
In bacteria, the major mechanism employed to overcome the
problem of ferric iron insolubility involves the production and
secretion of siderophores, which are molecules with a high affinity
and specificity for ferric iron. Siderophores are released into the
environment, where they chelate and thus solubilize ferric iron. The
resulting ferri-siderophore complexes can then be imported into the
cell through specific transport systems. The complex is thought to be
dissociated in the cytosol, releasing the bound iron, which can then be
incorporated into iron-requiring proteins. The proposed mechanisms
for the release of iron from siderophores involve either degradation
of the siderophore or reduction of the bound iron from the ferric
form to the ferrous state, resulting in loss of affinity of the iron for the
chelator. In Escherichia coli K-12, enterobactin (a catecholate), a
cyclic trimer of dihydroxybenzoylserine (DHBS), is the sole sidero-
phore produced. Following import of the highly stable ferri-
enterobactin complex, the iron is dissociated through the activity of
the Fes (ferric enterobactin esterase) protein. Fes acts by converting
enterobactin into monomeric DHBS units, generating a ferri-DHBS3
complex that is more readily dissociated (Raymond et al., 2003). Fes is
also reported to possess a distinct reductase activity, although it does
not appear to contain a redox centre that could mediate electron
transfer (Brickman & McIntosh, 1992; Hollifield & Neilands, 1978).
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Two Fes homologues (IroD and IroE) have recently been shown to be
involved in the breakdown of a glucosylated form of enterobactin
(namely salmochelin) in Salmonella enterica (Lin et al., 2005). E. coli
also utilizes FhuF, a cytosolic Fe–S protein that has been reported to
be required for the release of iron from ferri-ferrichrome (an
exogenous hydroxamate-type siderophore) complexes via a reduc-
tion mechanism (Matzanke et al., 2004). Appropriately, the genes
encoding Fes and FhuF are both induced by iron starvation. Thus,
E. coli appears to employ both a degradation and reduction
mechanism to achieve the release of iron from siderophores, although
the two mechanisms utilize distinct components and appear to target
very different siderophores.
Interestingly, E. coli possesses a third potential ferri-siderophore
dissociation protein designated YqjH. The corresponding gene
(yqjH) is iron-repressed in a Fur-dependent fashion (McHugh et al.,
2003) and the protein is homologous to ViuB of Vibrio cholerae. ViuB
is apparently cytosolic (like YqjH) and is required for the utilization
of ferri-vibriobactin, a catechol siderophore. In addition, viuB can
complement an fes E. coli mutant, strongly suggesting an iron-release
role (Butterton & Calderwood, 1994). However, the manner in which
ViuB functions remains unclear since the protein has not yet been
characterized. Many other YqjH homologues (e.g. BauF and MxcB)
are encoded by genes in loci specifying siderophore biosynthesis and
transport components (Mihara et al., 2004; Silakowski et al., 2000),
which is consistent with a role in iron release.
Here, we report the overproduction, purification, crystallization
and preliminary X-ray, UV–visible and mass-spectrometric analysis
of YqjH from E. coli. The three-dimensional structure of YqjH will
provide valuable insights into the mechanism of iron release from
siderophores in bacteria.
2. Materials and methods
2.1. Cloning, expression and purification
The E. coli K-12 yqjH gene was PCR-amplified from genomic
DNA using Accuzyme (Bioline) and cloned into the expression
vector pET101/D-TOPO (Promega) to generate pET101yqjH-
C(His6). Overexpression of the resultant YqjH-V5 epitope-His6
fusion protein (YqjH-His6, 32.4 kDa, containing 32 additional amino
acids at the C-terminus) was performed using E. coli BL21 (DE3)
cultured in L broth containing ampicillin (100 mg ml1) at 298 K and
250 rev min1. At a culture optical density at 650 nm of 0.5, the cells
were induced with 1 mM isopropyl -d-1-thiogalactopyranoside
(IPTG) and cultured for a further 8 h before harvesting by centri-
fugation for 20 min at 3000g and 277 K.
Cell pellets were resuspended in buffer A (25 mM HEPES pH 7.4,
50 mM imidazole, 0.2M NaCl) before being lysed at 138 MPa using a
French press. YqjH-His6 was then purified from the supernatant by
Ni2+-affinity chromatography (NTA-Sepharose, Qiagen) using buffer
A as the binding buffer and eluted with a linear gradient of buffer B
(buffer A containing 0.5M imidazole). The protein eluted as a single
peak at approximately 200 mM imidazole. The resulting protein was
dialysed against buffer C (25 mM HEPES pH 7.4, 20 mM mannitol,
1 mM EDTA, 1 mM DTT) and further purified by anion-exchange
chromatography (DEAE Sepharose FF, Pharmacia). YqjH-His6 was
eluted with a linear gradient of buffer D (buffer A containing 0.5M
NaCl) and was released from the column with approximately 200 mM
NaCl. The purified protein was dialysed against buffer C and samples
were stored in buffer C at 253 K. The final protein concentrations
used for each subsequent experiment were determined by the
method of Bradford (1976) using bovine serum albumin as standard.
2.2. UV–visible spectroscopy
The UV–visible spectra were recorded with the as-isolated YqjH-
His6 protein at 1.33 mg ml
1 (43.6 mM) in buffer containing 25 mM
HEPES pH 7.4 and 0.2M NaCl using a Unicam Helios  spectro-
photometer equipped with a 1 cm path-length quartz cuvette. The
scanning rate was 120 nm min1 and the bandwidth was 2 nm.
2.3. Mass spectrometry
Mass-spectrometric analysis was performed using an electrospray
ionization (ESI) mass spectrometer to determine the molecular
weight of the protein and associated cofactor. A sample of YqjH-His6
(45 ml at a concentration of 0.6 mg ml1 protein) in pure water was
diluted with 90 ml of a methanol/water (50:50) solution containing
0.1% formic acid. This mixture was then directly used for infusion
into the electrospray source of a Bruker MicroTOF high-perfor-
mance mass spectrometer. Similar solutions of two control proteins,
cytochrome c (12 361 Da) and myoglobin (16 952 Da), were also
applied at 0.1 and 1 mM (prepared as above) to confirm instrument
performance and for calibration. For each sample analysed, a volume
of 50 ml was infused at 2 ml min1 using a 100 ml syringe in a Harvard
syringe pump. Data were acquired over an m/z range of 100–5000.
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Figure 1
Crystallization of YqjH from E. coli. (a) Needles observed from initial screening,
PACT screen condition No. 1-1. (b) Optimized conditions from (a): 0.1M SPG
buffer pH 4.0 and 18% PEG 1500. The drop size was 2 ml + 2 ml and the protein
concentration was 8 mg ml1.
2.4. Crystallization
Purified YqjH-His6 was concentrated in buffer C (25 mM HEPES
pH 7.4, 20 mM mannitol, 1 mm EDTA, 1 mM DTT) to 8 mg ml1
using centrifugal membrane concentrators (Vivaspin; 5 kDa mole-
cular-weight cutoff). Initial crystallization screening was performed
manually in 2 + 2 ml drops using the hanging-drop vapour-diffusion
method in 24-well Linbro plates against the PACT screen (Molecular
Dimensions Ltd) at 291 K.
Initial conditions were found that gave crystal morphologies of
either needles or flattened rods (Fig. 1a). The most promising
condition [No. 1-1; 0.1M SPG buffer pH 4.0 and 25%(w/v) PEG
1500] was further optimized. Optimization of the PEG concentration
resulted in single rod-shaped crystals of typical dimensions 300  20
 20 mm that grew optimally from 0.1M SPG buffer pH 4.0 and
18%(w/v) PEG 1500 (Fig. 1b). Crystals from the optimized conditions
appeared in less than 24 h and grew to maximum dimensions within
3 d. The crystal quality was observed to degrade over a period of
6–14 d. The optimized crystals, harvested within one week of
appearance, were of suitable size and quality for X-ray diffraction
analysis.
2.5. Data collection and diffraction analysis
Typically, upon appearance YqjH-His6 crystals were cryoprotected
in mother liquor containing either 25%(w/v) PEG 550 MME or
25%(w/v) ethylene glycol by quick transfer directly from the hanging
drop. Diffraction data were collected on an ADSC Q315 CCD
detector at 100 K on the macromolecular crystallography beamline
station ID23-EH1 (ESRF, Grenoble, France). Data were collected to
a resolution of 3.0 A˚ and were integrated and scaled using the
programsMOSFLM v.6.2.4 (Leslie, 1992) and SCALA (Evans, 1997),
respectively, from the CCP4 program package (Collaborative
Computational Project, Number 4, 1994). The YqjH-His6 crystals
exhibited trigonal symmetry, space group P3121, and had unit-cell
parameters a = 75.23, c = 84.43 A˚ or a = 80.72, c = 84.59 A˚when using
PEG MME 550 (data set 1, Table 1) or ethylene glycol (data set 2,
Table 1) as the cryoprotectant, respectively. Solvent-content analysis
using the program MATTHEWS_COEF (Kantardjieff & Rupp,
2003) suggested solvent contents of 42 and 49.5% for the two unit
cells, respectively, for one molecule per asymmetric unit in each case.
Data-processing statistics for YqjH-His6 are shown in Table 1.
2.6. Phasing
Sequence-alignment searches of the PDB using WU-BLAST2
(http://www.ebi.ac.uk/blast2) revealed the protein that shares the
highest amino-acid sequence similarity (30% identity) to YqjH to be
the siderophore-interacting protein from Shewanella putrefaciens
CN-32 (PDB code 2gpj). Sequence alignment using ClustalW (http://
www.ebi.ac.uk/clustalw) was used to align the target sequence (YqjH)
and the model sequence. Inspection of the sequence alignment,
removal of nonconserved loops and mutation of aligned amino acids
to the target sequence resulted in a model consisting of residues
15–60, 79–89, 91–167, 171–254 and the FAD cofactor of the YqjH-
His6 sequence. Residue 254 is the C-terminal residue of the naturally
produced YqjH. This model was used as a search model for molecular
replacement using Phaser (McCoy et al., 2007). Using data collected
from a crystal cryoprotected in PEG MME 550 (data set 1) and a
crystal cryoprotected in ethylene glycol (data set 2), molecular-
replacement solutions were found in space group P3121 with an LLG
of 28 and 59, respectively. After rigid-body refinement in REFMAC
(Murshudov et al., 1997), R factor and Rfree values of 46.5 and 46.9
were found for data set 1 and of 50.9 and 50.7 for data set 2,
respectively. The resulting electron-density maps were clearly inter-
pretable (Fig. 2). The map clearly showed that both the location and
bound conformation of the FAD cofactor was in agreement with the
search model. Model building and refinement are in progress (against
data set 1) using the programs Coot (Emsley & Cowtan, 2004) and
REFMAC, respectively. Crystals of a selenomethionine-derivatized
protein have recently been obtained and structure determination for
this protein is in progress for independent phase improvement.
3. Results and discussion
3.1. Isolation and spectral characterization
yqjH from E. coli was cloned from genomic DNA and over-
expressed using a T7 promoter-based vector, generating a YqjH-V5
epitope-His6 fusion protein (YqjH-His6). The protein was purified by
Ni2+-affinity and anion-exchange chromatography and crystallized
readily in SPG buffer and PEG 1500, giving crystals that were
suitable for X-ray structure determination. The Pfam database indi-
cates that YqjH consists of two domains: an N-terminal FAD-
containing domain and a C-terminal ‘siderophore-interacting’
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Table 1
Data-collection and processing statistics for YqjH.
Values in parentheses correspond to the highest resolution shell (3.16–3.00 A˚). Data sets
1 and 2 refer to the PEG 550 MME and ethylene glycol cryoprotected data sets,
respectively.
Data set 1 Data set 2
Synchrotron beamline, ESRF ID23-EH1 ESRF ID23-EH1
Wavelength (A˚) 0.976 0.976
Space group P3121 P3121
Unit-cell parameters (A˚) a = 75.23, c = 84.43 a = 80.72, c = 84.59
Resolution range (A˚) 85.0–3.0 (3.16–3.0) 85.0–3.0 (3.16–3.0)
Rmerge† 11.7 (35.5) 10.2 (41.3)
No. of observations 19303 (2849) 23119 (3427)
No. of unique reflections 5825 (829) 6696 (956)
Mean I/(I) 10.4 (3.1) 10.6 (3.1)
Completeness (%) 99.8 (99.9) 99.9 (100)
Multiplicity 3.3 (3.4) 3.5 (3.6)
Solvent content (%) 42 49.5
Molecules per ASU 1 1
† Rmerge =
P
hkl
P
i jIiðhklÞ  hIðhklÞij=
P
hkl
P
i IiðhklÞ, where the outer summation is
over all unique reflections with multiple observations and the inner summation is over all
observations of each reflection.
Figure 2
Electron-density map of YqjH in the vicinity of the FAD cofactor at 3.0 A˚
resolution and contoured at 1. The FAD cofactor adopts a bent conformation.
domain. Consistent with this prediction, the isolated YqjH-His6
protein was found to be bright yellow.
Spectral analysis of YqjH-His6 confirmed the presence of an FAD-
like species (Fig. 3). The UV–visible spectrum of the as-isolated
protein was typical of that of proteins containing FAD in the oxidized
form, with absorption maxima at 380 and 456 nm and distinct
shoulders associated with the 456 nm peak located at 430 and 481 nm
(Table 2). Although the oxidized spectrum is similar to that observed
for other FAD-containing proteins, the shoulder at 430 nm is
indistinct in the spectra of FAD proteins in some cases. The
380:456:481 nm absorbance ratios for oxidized YqjH were 0.82:1:0.83.
Similar ratios are observed for the equivalent spectral features of
known FAD proteins presented in Table 2 (0.79–0.94:1:0.73–0.89).
Upon addition of reductant, the spectrum gradually changed,
reaching a fully reduced state that was not further altered by addi-
tional aliquots of reductant. The peaks/shoulders at 430, 456 and
481 nm were either greatly lessened upon reduction or eliminated
and an additional relatively minor peak appeared at 530 nm
(relative intensity of 0.18 compared with the oxidized spectrum at
456 nm) that was not apparent in the oxidized spectrum. The
diminished absorbance of the features centred at 456 nm is a typical
characteristic of FAD-containing proteins (Axley et al., 1997), as is
the appearance of a novel feature in the 530–540 nm region upon
reduction (Gadda & Fitzpatrick, 1998). Thus, the spectral character-
istics of YqjH can be considered to be typical of FAD-containing
proteins.
To confirm the identity of the protein isolated, as well as the
presence of FAD, the protein was subjected to ESI mass-spectro-
metric analysis. The spectrum of YqjH-His6 gave two main charge-
state envelopes as well as two low-mass singly charged ions. The first
envelope had a range of +24 to +49, which upon deconvolution gave a
molecular weight of 32 411 Da. The second envelope had a charge-
state range of approximately +15 to +22, which deconvoluted to a
molecular weight of 33 197 Da. In the low-mass region there
appeared a singly charged ion at m/z 786, along with a base peak at
m/z 477. The anticipated molecular weight of the YqjH-His6 poly-
peptide is 32 411.52 Da, which matches that corresponding to the first
envelope (32 411 Da), thus confirming the identity of the isolated
protein. The difference (786 Da) between the two major species
corresponds to the molecular weight of the FAD cofactor (also
786 Da). Therefore, the measured molecular weights are likely to
represent the protein in the FAD-bound and FAD-unbound states. In
the low-mass region, a singly charged ion at m/z 786 is present which
is likely to represent the FAD cofactor. The base peak at m/z 477
presumably represents the sodium salt of an FAD breakdown
product comprising FMN. Thus, the MS data confirm the presence of
the FAD cofactor.
3.2. Crystallization and structure determination
Crystallization experiments yielded crystals of needle or flattened
rod-like morphology. Diffraction-quality crystals were obtained by
optimization of the precipitant concentration. It was shown to be
possible to cryoprotect these crystals under two different conditions,
mother liquor plus 25%(w/v) PEG MME 550 or mother liquor plus
25%(w/v) ethylene glycol, both of which gave crystals that repro-
ducibly diffracted to at least 3.0 A˚ resolution. However, the unit-cell
parameters differed using the two cryoprotectant conditions. Whilst
the c unit-cell parameter is essentially unaltered, there is a significant
contraction of approximately 5 A˚ (or 6%) in the a and b unit-cell
parameters for the crystals cryoprotected in PEG MME 550 with
respect to those cryoprotected in ethylene glycol (Table 1).
YqjH shares a high sequence similarity with over 200 proposed
siderophore-interacting proteins (Pfam) and using either data set 1 or
2 (Table 1) it was possible to find a molecular-replacement solution
using the putative siderophore-interacting protein from S. putre-
faciens as the search model (30% identity, 51% similarity). The
structure shows a two-domain protein and a search of the SCOP
database revealed that the N-terminal domain shares structural
similarity with the riboflavin synthase/ferredoxin reductase FAD-
binding domain family and that the C-terminal domain belongs to the
ferredoxin reductase-like C-terminal NADP-linked domain family.
The FAD-binding site, which is located between the two domains,
shows three main features: stabilization of the negative charges of the
diphosphate group of the FAD via interactions with Arg86 and
His106, aromatic stacking interactions between Trp251, His106 and
the adenine moiety of FAD and a second aromatic stacking
arrangement between Tyr88, Tyr250 and the isoalloxazine ring. There
also appear to be hydrogen-bond interactions between the hydroxyl
O atoms of the ribose and the backbone atoms of residues His252 and
Lys254 and between the carboxylate O atoms of the isoalloxazine and
the backbone atoms of residues Thr89, Asp102 and Phe104. Details
crystallization communications
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Table 2
Comparison of UV–visible spectral parameters for the oxidized forms of YqjH and
FAD-containing proteins.
Absorbance values are equivalent to 1 mM protein concentrations. Pronounced
shoulders are in italics; absorbance peaks are in upright font. The relatively low
absorbance values exhibited for YqjH may reflect substoichiometric FAD occupancy.
YqjH† FNR‡ NAO§ UNAGEP Red}
Wavelength
(nm) A
Wavelength
(nm) A
Wavelength
(nm) A
Wavelength
(nm) A
380 6.19 390 11.50 384 9.25 374 9.67
430 6.31
456 7.57 468 12.25 446 11.50 464 12.22
481 6.31 503 9.50 464 10.25 495 8.89
† Data derived from Fig. 3. ‡ Ferredoxin-NADP+ reductase from Anabaena PCC 7119
(Faro et al., 2002). § Nitroalkane oxidase from Fusarium oxysporum (Gadda &
Fitzpatrick, 1998). } UDP-N-acetylenolpyruvylglucosamine reductase from E. coli
(Axley et al., 1997).
Figure 3
UV–visible spectra of reduced and oxidized YqjH. The oxidized protein (o) was
that obtained as isolated in an aerobic solution. The protein was reduced (r) by
addition of a few grains of sodium dithionite and the spectrum was subsequently
recorded at 5 min intervals (5, 10, 15, 20, 25 min). No further changes in the
spectrum were observed when additional aliquots of dithionite were combined with
the sample (+r). The inset shows the entire spectrum of the oxidized protein (as
isolated) on an expanded scale.
of these interactions will be discussed following structure refinement.
Furthermore, once complete, this will enable structural comparisons
with related proteins, which may reveal features that differentiate the
various family members and help to shed light on the mechanism
employed to release iron from siderophores.
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